The Patent Finder
US

Salt Formulations for the Fermentation of Marine Microorganisms

US 8,986,971 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jun 23, 2033 · High confidence

Filed Sep 24, 2007 as application 11/860,491 · Granted Mar 24, 2015
Base term plus 2099 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2007 2033
Clock starts
Sep 24, 2007
Term ends
Jun 23, 2033
Granted
Mar 24, 2015
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
2,099
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 2099 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 24, 2007, when this application, 11/860,491, was filedSep 24, 2027High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+2099 days, USPTO patent term adjustment recordJun 23, 2033High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 23, 2033High confidence

This family

US 8,986,971this patent
Jun 2033
Jun 2033
US 10,011,814Lapsed on the fee record
Jul 2026
Jul 2026
US 10,793,824In force
Nov 2027
Nov 2027
Application 17/006,334Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 19, 2008
Reel 20529, frame 853
Lam, Kin Sing; Tsueng, GingerNereus Pharmaceuticals, Inc.Assignment of Assignor's Interest
May 21, 2009
Reel 22719, frame 115
Nereus Pharmaceuticals, Inc.HBM Bioventures (Cayman) Ltd.; HBM Biocapital (Eur) L.P.; HBM Biocapital (Usd) L.P.; Private Life Biomed AG; Alstertor Private Life GmbH & Co. KG; Advent Healthcare and Life Sciences III Limited Partnership; Advent Healthcare and Life Sciences III-A Limited Partnership; Advent Partners HLS III Limited Partnership; Pacific Venture Group II, L.P.; Pvg Associates Ii, L.p.; Forward Ventures Iv, L.p.; Forward Ventures IV B, L.P.; Gimv N.V.; Gimv Adviesbeheer Life Sciences N.V.; Lotus Bioscience Investment Holds Ltd.; Novartis Bioventure Fund / Novartis International Aig; Hensler, Mary; Jacobs, Robert; WS Investment Company; Genavent Partners LP; Astellas Venture Fund I LP; Roche Finance Ltd.; Alta California Partners II, L.P.; Alta Embarcadero Partners II, LLC; Alta California Partners II, L.P. - New PoolSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.HBM Bioventures (Cayman) Ltd.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.HBM Biocapital (Eur) L.P.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.HBM Biocapital (Usd) L.P.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Private Life Biomed AGSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Alstertor Private Life GmbH & Co. KGSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Advent Healthcare and Life Sciences III Limited PartnershipSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Advent Healthcare and Life Sciences III-A Limited PartnershipSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Advent Partners HLS III Limited PartnershipSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Pacific Venture Group II, L.P.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Pvg Associates Ii, L.p.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Forward Ventures Iv, L.p.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Forward Ventures IV B, L.P.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Gimv N.V.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Gimv Adviesbeheer Life Sciences N.V.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Lotus Bioscience Investment Holds Ltd.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Novartis Bioventure Fund / Novartis International AigSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Hensler, MarySecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Jacobs, RobertSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.WS Investment CompanySecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Genavent Partners LPSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Astellas Venture Fund I LPSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Roche Finance Ltd.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Alta California Partners II, L.P.Security Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Alta Embarcadero Partners II, LLCSecurity Agreement
May 21, 2009
reel/frame not recorded
Nereus Pharmaceuticals, Inc.Alta California Partners II, L.P. - New PoolSecurity Agreement
Feb 28, 2013
Reel 29899, frame 101
Nereus Pharmaceuticals, Inc.Triphase Research and Development I Corp.Assignment of Assignor's Interest
Nov 15, 2016
Reel 40327, frame 264
HBM Vioventures (Cayman) Ltd.; HBM Biocapital (Eur) L.P.; HBM Biocapital (Usd) L.P.; Private Life Biomed AG; Alstertor Private Life GmbH & Co. KG; Advent Healthcare and Life Sciences III Limited Partnership; Advent Healthcare and Life Sciences III-A Limited Partnership; Advent Partners HLS III Limited Partnership; Pacific Venture Group II, L.P.; Pvg Associates Ii, L.p.; Forward Ventures Iv, L.p.; Forward Ventures IV B, L.P.; Gimv N.V.; Gimv Adviesbeheer Life Sciences N.V.; Lotus Bioscience Investment Holds Ltd.; Novartis Bioventure Fund / Novartis International Aig; Hensler, Mary; Jacobs, Robert; WS Investment Company; Genavent Partners LP; Astellas Venture Fund I LP; Roche Finance Ltd.; Alta California Partners II, L.P.; Alta Embarcardero Partner II, LLC; Alta California Partners II, L.P. - New PoolNereus Pharmaceuticals, Inc.Release of Security Interest
Feb 13, 2017
Reel 41698, frame 404
Nereus Pharmaceuticals, Inc.Triphase Research and Development I Corp.Assignment of Assignor's Interest
Apr 29, 2024
Reel 67256, frame 264
Celgene Research and Development I ULC, Formerly Known as Triphase Research and Development I Corp.1096271 B.C. Unlimited Liability CompanyAssignment of Assignor's Interest
Apr 29, 2024
Reel 67256, frame 286
1096271 B.C. Unlimited Liability CompanyCelgene Tri a Holdings Ltd.Assignment of Assignor's Interest
Apr 29, 2024
Reel 67256, frame 305
Celgene Tri a Holdings Ltd.Celgene International II SARLAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited